A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

Aviat Networks, Inc. ("Aviat Networks," "Aviat," or the "Company"), , the leading expert in wireless transport and access solutions, today reported financial results for its fiscal 2025 second quarter ...

Q32 Bio Inc. ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in a ...

Researchers at the University of Toronto have invented a new method that uses DNA sequencing to measure metabolites. This ...

Evolution has been fine-tuning life at the molecular level for billions of years. Proteins, the fundamental building blocks of life, have evolved through this process to perform various biological ...

Application: Himachal Pradesh Technical University (HPTU) has started the application process for Himachal Pradesh CET i.e.

NGM Biopharmaceuticals, Inc. (NGM Bio or Company) today announced that it has appointed Wendy Yeh, M.D. as Chief Medical Officer. A seasoned clinical development leader and accomplished clinician, Dr.

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Macquarie University researchers, alongside an international team, have achieved a significant milestone in synthetic biology by completing the final chromosome of the world's first synthetic yeast ...